Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thomas Sangiovanni

Foot and Ankle Surgery Coral Gables, FL Medical Doctor

NPI 1518932896 CMS profile 341432

1150 Campo Sano Ave, Coral Gables, FL 33146

Open in the dashboard

General payments

$2,119,963

329 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$12,577,392

5 holdings reported · through program year 2025

Research they led as principal investigator

$4,245 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Thomas Sangiovanni of Coral Gables, FL is reported in the CMS Open Payments database as having received $2,119,963 across 329 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $4,245 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $12,577,392 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $43,729 33
2024 General $182,829 45
2023 General $82,182 65
2022 General $206,071 64
2021 General $291,038 44
2020 General $959,570 32
2019 General $354,543 46
2020 Ownership $6,452,614 2
2019 Ownership $6,124,778 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Sangiovanni
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to Thomas Sangiovanni were reported at $43,729. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year Thomas Sangiovanni Foot and Ankle Surgery median Middle half National median
2019 $354,543 $1,327 $279–$5,421 $163
2020 $959,570 $795 $121–$3,473 $114
2021 $291,038 $1,289 $201–$4,963 $132
2022 $206,071 $1,539 $270–$6,067 $149
2023 $82,182 $1,117 $257–$5,264 $160
2024 $182,829 $1,064 $235–$4,944 $164
2025 $43,729 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Paragon 28, Inc. $2,005,900 243 payments
  2. Avitus Orthopaedics, Inc. $49,095 10 payments
  3. Zimmer Biomet Holdings, Inc. $20,525 22 payments
  4. Wright Medical Technology, Inc. $19,265 4 payments
  5. Anika Therapeutics, Inc. $17,802 5 payments
  6. Southern Edge Orthopaedics, Inc. $3,562 5 payments
  7. Arthrex, Inc. $1,538 17 payments
  8. Citieffe, Inc. $460 1 payment
  9. OSSIO Inc. $412 3 payments
  10. Stryker Corporation $393 3 payments
  11. Other $1,011 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $957,370 56 payments
  2. Current or prospective ownership or investment interest $648,960 4 payments
  3. Consulting Fee $424,482 30 payments
  4. Travel and Lodging $55,242 119 payments
  5. Education $21,999 12 payments
  6. Food and Beverage $8,228 104 payments
  7. Acquisitions $3,329 1 payment
  8. Long term medical supply or device loan $354 3 payments
Products named General payments · program years 2019–2025
  1. Product Portfolio $456,156 64 payments
  2. PORTFOLIO $266,156 88 payments
  3. MAX LOCK $19,265 4 payments
  4. AccuFill $9,970 3 payments
  5. Grappler $9,149 8 payments
  6. APEX 3D $6,976 11 payments
  7. Phantom Fibula Nail $5,640 1 payment
  8. Arcos $5,300 2 payments
  9. Persona $2,507 3 payments
  10. MONSTER $1,574 1 payment
  11. Other $9,368 66 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$36,671

Medicare's payments for the services billed

Medicare patients

96

Average age 74

Services billed

418

57 women, 39 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 38%
Diabetes 27%
Osteoporosis 25%
Chronic kidney disease 19%
Depression 19%
Atrial fibrillation 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

329 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record